Essence Magazine:
By Brooklyn White ·September 20, 2021 Updated
There is hope for a COVID-19 vaccine for young children as they head back to school.
According to study results released this morning, Pfizer and BioNTech have announced positive results following COVID-19 vaccine trials in children aged 5-11. The vaccine was “safe, well tolerated and showed robust neutralizing antibody responses” and administered in two doses, 21 days apart.
The doses were rather low, as 10μg (micrograms) are only
This post first appeared in Essence Magazine. Read the original article.